arrow
T

Torsten Keßler

university of munster
H指数:30
被引数:2,969

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Variations in surgical strategies and treatment allocation for retroperitoneal sarcomas across German-speaking sarcoma centres

德语区肉瘤中心在腹膜后肉瘤的手术策略和治疗分配方面的差异

EJSO
IF2.9
2026-08-010
PRE
Undifferentiated pleomorphic sarcoma of bone (UPSB) treated in the German-speaking countries. A report of 132 unselected patients from the Cooperative Osteosarcoma Study Group (COSS)
2026-01-200
OAAI
The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers (vol 151, 30, 2024)

软组织肉瘤环状试验:一项基于病例的分析,评估德国21个讲德语的软组织肉瘤中心之间的中心间一致性(卷151,期30,2024)

2025-04-240
OA
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse

使用基质锚定细胞因子增强ADCC: F16IL2和BI 836858移植后AML复发的1期试验

2022-06-228
OAAI
The role of autologous stem cell transplantation (ASCT) in aggressive B-cell lymphomas: real-world data from a retrospective single-center analysis

自体干细胞移植 (ASCT) 在侵袭性b细胞淋巴瘤中的作用: 来自回顾性单中心分析的真实数据

2021-09-0312
OAAI
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
2021-07-0123
OAAI
Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomas
2021-06-0110
PRE
The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia
LEUKEMIA
IF13.4
2019-06-1028
PREAI
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)

帕唑帕尼在急性髓性白血病 (AML),复发或难治性或初次诊断而无强化治疗选择 (PazoAML) 的患者中的II期临床试验

2019-03-2111
PREAI